“…Seipin might control ER PL metabolism, especially that of PA, via protein–protein interactions of major lipid synthesizing enzymes, such as AGPAT2, lipin-1, and GPATs (Sim et al., 2012; Talukder et al., 2015; Pagac et al., 2016; Gao et al., 2019b; Sim et al., 2020). Indeed, GPAT activity was altered in a number of seipin depleted systems, suggesting that seipin negatively regulates GPAT activity to inhibit aberrant expansion of LDs (Pagac et al., 2016).…”